Lockheed Martin (LMT) Gets $674 UBS Price Target. Can Missile Demand Drive More Upside?
UBS upgraded Lockheed Martin (LMT) to Buy with a $674 price target, citing 9% annual revenue growth through 2028. The analyst noted a 15% valuation discount vs. the S&P 500. Lockheed's missile backlog is growing, and it delivered the first F-35A to Germany. Risks include geopolitical exposure and potential cuts in Germany's F-35 program.
How this was made

The 30-second read
Why it matters
The analyst upgrade reinforces the positive narrative around the missile backlog and could attract new capital.
Market read
Analyst upgrade with a higher price target provides a clear short‑term trading catalyst for LMT.
What to watch
Potential geopolitical risk to backlog and reliance on large government contracts.
Background
Lockheed Martin announced a new PrSM missile award and highlighted its Javelin joint venture with Raytheon and Tata Advanced Systems.
Ticker impact
UBS upgraded Lockheed Martin to Buy and raised its price target to $674, citing missile demand and a growing backlog.
likely upward pressure as the market prices in the higher target and growth outlook
Analyst upgrade with a concrete price target and growth assumptions typically drives buying interest.
Market effects
May lift other defense and aerospace stocks as missile demand is highlighted.
Positive for U.S. defense sector investors.
Limited to defense-focused investors; no broad market effect.
Counterpoint
If missile demand stalls or budget cuts occur, the upgrade could be premature.
Key entities
- companyLockheed Martin
U.S. defense contractor receiving missile contracts.
- analyst_firmUBS
Issued the upgrade and new price target.


